Inductive Bio is thrilled to announce that it has secured $25,000,000 in its latest funding round—a milestone that marks a significant leap forward in the company’s mission to revolutionize the way ADMET challenges are addressed in the biotech and pharmaceutical industries. Known for bringing together a unique blend of data, machine learning, and advanced software solutions, Inductive Bio has consistently demonstrated its capability to deploy rapid and accurate solutions to some of the most complex absorption, distribution, metabolism, excretion, and toxicity (ADMET) issues. This fresh infusion of capital will be strategically allocated towards expanding the company’s research and development efforts, enhancing its proprietary technological platforms, and scaling up operational capabilities to meet the growing demand for innovative drug development solutions. By bolstering its infrastructure and expertise, Inductive Bio aims to streamline the drug discovery process even further, enabling more efficient prediction models and risk assessments that significantly reduce the timeline and costs associated with bringing new therapeutics to market. Furthermore, this funding will empower the company to invest in top-tier talent and forge critical industry partnerships, ensuring that its approach remains at the cutting edge of scientific and technological advancements. As the biotech landscape continues to evolve rapidly, Inductive Bio’s commitment to integrating robust data analytics and machine learning into core development processes not only enhances its competitive advantage but also promises to drive substantial improvements in patient outcomes across a variety of therapeutic areas. This groundbreaking investment underscores the growing confidence in Inductive Bio’s strategic vision and sets the stage for a future brimming with transformative innovations in drug discovery and development.
Inductive Bio Closes $25M Series A to Accelerate ADMET Innovation and Breakthroughs
Recently funded · $25.0M Series aBiotechnology Research
Get the full Inductive Bio company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
